According to Smith & Nephew 's latest financial reports and stock price the company's current number of shares outstanding is 446,500,000. At the end of 2014 the company had 446,500,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2014 | 0.44 B | 149.34% |
2013 | 0.17 B | 0.45% |
2012 | 0.17 B | |
2011 | 0.17 B | 0.45% |
2010 | 0.17 B | 0.45% |
2009 | 0.17 B | -1.01% |
2008 | 0.17 B | -4.19% |
2007 | 0.18 B | -1.06% |
2006 | 0.18 B | -0.32% |
2005 | 0.18 B | 0.96% |
2004 | 0.18 B | -49.66% |
2003 | 0.37 B | 100.86% |
2002 | 0.18 B | 0.4% |
2001 | 0.18 B |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | 2,634,300,000 | 489.99% | ๐บ๐ธ USA |
![]() Boston Scientific BSX | 1,435,800,000 | 221.57% | ๐บ๐ธ USA |
![]() Edwards Lifesciences EW | 607,500,000 | 36.06% | ๐บ๐ธ USA |
![]() Stryker Corporation SYK | 379,000,000 | -15.12% | ๐บ๐ธ USA |
![]() Orthofix Medical
OFIX | 20,200,000 | -95.48% | ๐บ๐ธ USA |
![]() CONMED CNMD | 30,511,000 | -93.17% | ๐บ๐ธ USA |